70 related articles for article (PubMed ID: 2455198)
1. Role of the central nervous system in human secondary hypertension.
Mathias CJ
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S93-9. PubMed ID: 2455198
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and hormonal effects of clonidine in patients with essential hypertension and renal hypertension.
Mathias CJ; Wilkinson AH; Stone FA; Peart S
J Hypertens Suppl; 1985 Dec; 3(4):S73-5. PubMed ID: 3913757
[TBL] [Abstract][Full Text] [Related]
3. Clonidine in unilateral renal artery stenosis and unilateral renal parenchymal disease--similar antihypertensive but different renin suppressive effects.
Mathias CJ; Wilkinson AH; Pike FA; Sever PS; Peart WS
J Hypertens Suppl; 1983 Dec; 1(2):123-5. PubMed ID: 6400111
[TBL] [Abstract][Full Text] [Related]
4. [The central nervous system, regulation of blood pressure and hypertension. Recent advances in the role of the central nervous system in the regulation of blood pressure].
Unger T; Ganten D; Lang RE
Fortschr Med; 1984 Jun; 102(22):605-8. PubMed ID: 6147303
[TBL] [Abstract][Full Text] [Related]
5. Role of sympathetic efferent nerves in blood pressure regulation and in hypertension.
Mathias CJ
Hypertension; 1991 Nov; 18(5 Suppl):III22-30. PubMed ID: 1937684
[TBL] [Abstract][Full Text] [Related]
6. Baroreflexes and cardiovascular regulation in hypertension.
Head GA
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S7-16. PubMed ID: 8642810
[TBL] [Abstract][Full Text] [Related]
7. Neurogenic components of hypertension in human renal artery stenosis.
Mathias CJ; Kooner JS; Peart S
Clin Exp Hypertens A; 1987; 9 Suppl 1():293-306. PubMed ID: 3315326
[TBL] [Abstract][Full Text] [Related]
8. The kidney and the neurogenic control of blood pressure in renal disease.
Campese VM
J Nephrol; 2000; 13(3):221-4. PubMed ID: 10928299
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.
Phillips JK
Clin Exp Pharmacol Physiol; 2005; 32(5-6):415-8. PubMed ID: 15854151
[TBL] [Abstract][Full Text] [Related]
10. Neurogenic factors in hypertension: therapeutic implications.
Campese VM
Ann Ital Med Int; 1994 Oct; 9 Suppl():39S-43S. PubMed ID: 7857755
[TBL] [Abstract][Full Text] [Related]
11. Role of the sympathetic nervous system in the maintenance of hypertension in rats harboring pheochromocytoma.
Prokocimer PG; Maze M; Hoffman BB
J Pharmacol Exp Ther; 1987 Jun; 241(3):870-4. PubMed ID: 3598906
[TBL] [Abstract][Full Text] [Related]
12. [Influence of baroreceptors on hypertension, pharmacotherapy with conversion enzyme inhibitors].
Dominiak P; Blöchl A; Permanetter B
Z Kardiol; 1989; 78 Suppl 7():187-92. PubMed ID: 2696253
[TBL] [Abstract][Full Text] [Related]
13. Renal nerves and hypertension: an update.
Katholi RE
Fed Proc; 1985 Oct; 44(13):2846-50. PubMed ID: 3899731
[TBL] [Abstract][Full Text] [Related]
14. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
15. Hypertension in children with neurofibromatosis.
Virdis R; Balestrazzi P; Zampolli M; Donadio A; Street M; Lorenzetti E
J Hum Hypertens; 1994 May; 8(5):395-7. PubMed ID: 8064789
[TBL] [Abstract][Full Text] [Related]
16. Orthostatic hypotension and paroxysmal hypertension in humans with high spinal cord injury.
Mathias CJ
Prog Brain Res; 2006; 152():231-43. PubMed ID: 16198704
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
19. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
20. Volume and vasoconstriction in experimental renovascular hypertension.
Freeman RH; Davis JO; Seymour AA
Fed Proc; 1982 Jun; 41(8):2409-14. PubMed ID: 7044827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
